Ferulamide
CAS No. 61012-31-5
Ferulamide( 4-Hydroxy-3-methoxycinnamide )
Catalog No. M29143 CAS No. 61012-31-5
Ferulamide, a Ferulic acid derivative, shows potent inhibitory activity against arachidonic acid-induced platelet aggregation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 410 | Get Quote |
|
| 10MG | 602 | Get Quote |
|
| 25MG | 945 | Get Quote |
|
| 50MG | 1278 | Get Quote |
|
| 100MG | 1728 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFerulamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionFerulamide, a Ferulic acid derivative, shows potent inhibitory activity against arachidonic acid-induced platelet aggregation.
-
DescriptionFerulamide, a Ferulic acid derivative, shows potent inhibitory activity against arachidonic acid-induced platelet aggregation.(In Vitro):A series of Ferulamide derivatives were prepared and evaluated for their anti-platelet activities. Some of these compounds showed potent inhibitory activity against arachidonic acid-induced platelet aggregation. Their structure-activity relationships are also discussed.
-
In Vitro——
-
In Vivo——
-
Synonyms4-Hydroxy-3-methoxycinnamide
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number61012-31-5
-
Formula Weight193.202
-
Molecular FormulaC10H11NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc(cc(/C=C/C(N)=O)cc1)c1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Citrusin C
Citrusin is a useful organic compound for research related to life sciences.
-
β-D-Glucan
β-D-Glucan is a compound that targets tumor-associated macrophages with antitumor activity and modulates the immune response in necrotizing pancreatitis.
-
TFMB-(R)-2-HG
TFMB-(R)-2-HG is a carcinogenic factor in Acute myeloid leukemia (AML). TFMB-(R)-2-HG impairs SCF ER-Hoxb8 cell differentiation in response to estrogen withdrawal.
Cart
sales@molnova.com